LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

Search

McKesson Corp

Geschlossen

BrancheGesundheitswesen

851 -0.84

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

844.16

Max

852.31

Schlüsselkennzahlen

By Trading Economics

Einkommen

-522M

784M

Verkäufe

7B

98B

KGV

Branchendurchschnitt

32.891

77.256

Dividendenrendite

0.35

Gewinnspanne

0.801

Angestellte

43,000

EBITDA

-454M

1.3B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+5.27% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.35%

2.33%

Nächste Dividendenausschüttung

2. Jan. 2026

Nächstes Ex-Dividendendatum

1. Dez. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

13B

102B

Vorheriger Eröffnungskurs

851.84

Vorheriger Schlusskurs

851

Nachrichtenstimmung

By Acuity

35%

65%

104 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

McKesson Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

7. Nov. 2025, 21:06 UTC

Wichtige Markttreiber

JBS Down After Trump Calls for Probe into Meat-Packing Companies

8. Nov. 2025, 18:10 UTC

Ergebnisse

10 Defensive Stocks with Market-Beating Yields -- Barrons.com

8. Nov. 2025, 13:10 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8. Nov. 2025, 12:00 UTC

Ergebnisse

Apple's iPhone Air Is a Marketing Win and a Sales Flop -- WSJ

8. Nov. 2025, 10:30 UTC

Ergebnisse

Why Car Insurers Are Under Pressure to Cut Rates -- Heard on the Street -- WSJ

8. Nov. 2025, 03:50 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8. Nov. 2025, 03:41 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8. Nov. 2025, 03:07 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7. Nov. 2025, 22:36 UTC

Ergebnisse

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

7. Nov. 2025, 22:22 UTC

Ergebnisse

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

7. Nov. 2025, 22:03 UTC

Ergebnisse

Constellation Software 3Q Rev $2.95B >CSU.T

7. Nov. 2025, 22:03 UTC

Ergebnisse

Constellation Software 3Q Net $210M >CSU.T

7. Nov. 2025, 22:03 UTC

Ergebnisse

Constellation Software 3Q EPS $9.89 >CSU.T

7. Nov. 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

7. Nov. 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

7. Nov. 2025, 20:59 UTC

Ergebnisse

Palantir's CEO Says His Earnings Were the Best Ever. They Weren't Even the Best of the Week. -- Barrons.com

7. Nov. 2025, 20:26 UTC

Market Talk

Natural U.S. Gas Futures Extend Rally to Three Weeks -- Market Talk

7. Nov. 2025, 20:22 UTC

Ergebnisse

Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. -- Barrons.com

7. Nov. 2025, 20:04 UTC

Market Talk

Oil Futures Close Choppy Week With Losses -- Market Talk

7. Nov. 2025, 19:34 UTC

Market Talk

Gold Posts Small Gain for Week -- Market Talk

7. Nov. 2025, 19:31 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Prices of Gas-Fired Power Plants Have Room to Grow -- Market Talk

7. Nov. 2025, 19:17 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Tesla, Expedia, Take-Two, Block, Affirm, Sunrun, Globus Medical, JFrog, and More -- Barrons.com

7. Nov. 2025, 19:09 UTC

Ergebnisse

Wendy's Turnaround Won't Be Easy. Earnings, and the Stock, Tell the Story. -- Barrons.com

7. Nov. 2025, 19:08 UTC

Ergebnisse

KKR Defied Private-Equity Fundraising Slump in the Third Quarter -- WSJ

7. Nov. 2025, 18:31 UTC

Market Talk

U.S. Oil RIg Count Unchanged at 414 -- Market Talk

7. Nov. 2025, 17:27 UTC

Market Talk

EPA Announces New Exemptions to Biofuel Blending Rules -- Market Talk

7. Nov. 2025, 17:20 UTC

Market Talk

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

7. Nov. 2025, 17:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

7. Nov. 2025, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7. Nov. 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

Peer-Vergleich

Kursveränderung

McKesson Corp Prognose

Kursziel

By TipRanks

5.27% Vorteil

12-Monats-Prognose

Durchschnitt 896.92 USD  5.27%

Hoch 1,000 USD

Tief 775 USD

Basierend auf 15 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McKesson Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

15 ratings

13

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

681.92 / 707.28Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

No Evidence

Langfristig

No Evidence

Stimmung

By Acuity

104 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat